Dixian Luo
Overview
Explore the profile of Dixian Luo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wang J, Duan Z, Luo D
Research (Wash D C)
. 2024 Jan;
7:0296.
PMID: 38288060
In the post-COVID-19 pandemic era, the long-term surveillance of pathogens is still important. The rapid detection of pathogens facilitates the accurate and convenient real-time monitoring of microbial contamination and improves...
12.
Chen Y, Gong H, Tang D, Yu L, Long S, Zheng B, et al.
PeerJ
. 2023 May;
11:e15294.
PMID: 37255592
Background: Sepsis is a serious infection-induced response in the host, which can result in life-threatening organ dysfunction. It is of great importance to unravel the relationship between sepsis and host...
13.
Li G, Sun Y, Huang Y, Lian J, Wu S, Luo D, et al.
BMC Cancer
. 2023 May;
23(1):473.
PMID: 37221488
Background: The contributive role of the microbiome in tumor progression has been reported in multiple studies, such as the Fusobacterium nucleatum (F. nucleatum) in breast cancer (BC). This study aimed...
14.
Zuo Q, Xu Q, Li Z, Luo D, Peng H, Duan Z
Histol Histopathol
. 2023 May;
39(2):239-250.
PMID: 37212515
This study is to investigate the regulation of TRIM3/FABP4 on colorectal cancer (CRC) cell migration and lipid metabolism. After transfection of HCT116, LoVo, or SW480 cells, the expression of FABP4,...
15.
Zuo Q, Xu Q, Li Z, Luo D, Peng H, Duan Z
Anticancer Drugs
. 2023 Apr;
34(10):1171-1182.
PMID: 37067981
Oxaliplatin (OXA) is a standard agent for colorectal cancer (CRC) adjuvant chemotherapy. However, acquired and intrinsic OXA resistance is a primary challenge for CRC treatment. This study investigates the function...
16.
Zhou Y, Lin Y, Li W, Liu Q, Gong H, Li Y, et al.
Medicine (Baltimore)
. 2023 Feb;
102(8):e33041.
PMID: 36827074
The human aldo-keto reductase (AKRs) superfamily is involved in the development of various tumors. However, the different expression patterns of AKRs and their prognostic value in gastric cancer (GC) have...
17.
Yang Y, Mai Z, Zhang Y, Yu Z, Li W, Zhang Y, et al.
ACS Nano
. 2023 Jan;
PMID: 36602608
Chemoresistance is a formidable issue in clinical anticancer therapy and is pertinent to the lowered efficacies of chemotherapeutics and the activated tumor self-repairing proceedings. Herein, bifunctional amphiphiles containing galactose ligands...
18.
Wen X, Pu H, Liu Q, Guo Z, Luo D
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551512
Cancer is the second leading cause of death in the world and seriously affects the quality of life of patients. The diagnostic techniques for tumors mainly include tumor biomarker detection,...
19.
Pu H, Wen X, Luo D, Guo Z
J Steroid Biochem Mol Biol
. 2022 Oct;
227:106199.
PMID: 36191723
The uterus and breasts are hormone-responsive tissues. Progesterone and estradiol regulate gonadotropin secretion, prepare the endometrium for implantation, maintain pregnancy, and regulate the differentiation of breast tissue. Dysregulation of these...
20.
Liu Q, Chen S, Wang L, Duan Z, Xie F, Zhao G, et al.
Natl Sci Rev
. 2022 Sep;
9(9):nwac149.
PMID: 36128455
No abstract available.